NASDAQ:VKTX | Key Financial Ratios | Viking Therapeutics, Inc.

Complete source-backed ratio history.

Available history
2014-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-304.72-102.47%-130.98%
2026-03-315.72-77.66%-94.11%
2025-12-319.33-50.25%-56.28%
2025-09-3028.34-32.11%-33.29%
2025-06-3025.86-20.72%-21.57%
2025-03-3144.25-14.79%-15.14%
2024-12-3133.09-12.11%-12.49%
2024-09-3036.47-10.57%-10.88%
2024-06-3037.69-10.22%-10.50%
2024-03-3129.48-9.69%-10.04%
2023-12-3119.19-23.31%-24.65%
2023-09-3028.44-21.13%-21.96%
2023-06-3029.63-18.49%-19.19%
2023-03-319.55-47.91%-53.93%
2022-12-317.61-40.86%-47.39%
2022-09-3011.74-36.99%-40.76%
2022-06-3012.1-32.58%-35.79%
2022-03-3117.15-29.27%-31.32%
2021-12-3123.98-26.10%-27.24%
2021-09-3019.76-23.87%-25.14%
2021-06-3018.46-20.87%-22.06%
2021-03-3119.35-17.52%-18.47%
2020-12-3121.12-15.40%-16.16%
2020-09-3027.09-13.65%-14.18%
2020-06-3029.89-11.96%-12.38%
2020-03-3132.36-11.02%-11.38%
2019-12-3141.83-9.07%-9.30%
2019-09-3046.71-8.12%-8.31%
2019-06-3052.19-8.30%-8.47%
2019-03-3160.82-7.81%-7.96%
2018-12-3166.4-7.30%-7.41%
2018-09-3064.65-6.81%-6.92%
2018-06-3035.14-14.13%-14.54%
2018-03-3112.42-23.94%-26.03%
2017-12-312.52-93.02%-152.84%
2017-09-301.2-170.09%-904.67%
2017-06-301.85-124.62%-270.89%
2017-03-314.34-108.01%-216.89%
2016-12-312.16-101.35%-183.17%
2016-09-302.57-99.14%-158.31%
2016-06-303.19-92.23%-133.80%
2016-03-316.34-166.81%-368.81%
2015-12-317.69-151.59%-268.24%
2015-09-303.31-89.01%-127.53%
2015-06-304.57-55.90%-71.57%
2015-03-310.01-988.21%98.30%
2014-12-310.03-719.13%98.90%

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-319.33-50.25%-56.28%
2024-12-3133.09-12.11%-12.49%
2023-12-3119.19-23.31%-24.65%
2022-12-317.61-40.86%-47.39%
2021-12-3123.98-26.10%-27.24%
2020-12-3121.12-15.40%-16.16%
2019-12-3141.83-9.07%-9.30%
2018-12-3166.4-7.30%-7.41%
2017-12-312.52-93.02%-152.84%
2016-12-312.16-101.35%-183.17%
2015-12-317.69-151.59%-268.24%
2014-12-310.03-719.13%98.90%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.